Clinical Trial Update: Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is recruiting to test whether fluoxetine can modify colorectal tumor immune cells before surgery in patients with colorectal cancer. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Fluoxetine (Fluoxetine)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Colorectal Adenocarcinoma | Phase 1 | Status: RECRUITING